Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue
- PMID: 19754873
- PMCID: PMC2896500
- DOI: 10.1111/j.1742-4658.2009.07303.x
Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue
Abstract
Adipose tissue is an endocrine organ made up of adipocytes, various stromal cells, resident and infiltrating immune cells, and an extensive endothelial network. Adipose secretory products, collectively referred to as adipokines, have been identified as contributors to the negative consequences of adipose tissue expansion that include cardiovascular disease, diabetes and cancer. Systemic blood circulation provides transport capabilities for adipokines and fuels for proper adipose tissue function. Adipose tissue microcirculation is heavily impacted by adipose tissue expansion, some adipokines can induce endothelial dysfunction, and angiogenesis is necessary to counter hypoxia arising as a result of tissue expansion. Tumors, such as invasive lesions in the mammary gland, co-opt the adipose tissue microvasculature for local growth and metastatic spread. Lymphatic circulation, an area that has received little metabolic attention, provides an important route for dietary and peripheral lipid transport. We review adipose circulation as a whole and focus on the established and potential interplay between adipose tissue and the microvascular endothelium.
Figures
Similar articles
-
The impact of adipokines on vascular networks in adipose tissue.Cytokine Growth Factor Rev. 2023 Feb;69:61-72. doi: 10.1016/j.cytogfr.2022.07.008. Epub 2022 Jul 23. Cytokine Growth Factor Rev. 2023. PMID: 35953434 Review.
-
Adipose tissue dysfunction in obesity.Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Exp Clin Endocrinol Diabetes. 2009. PMID: 19358089 Review.
-
[Adipose tissue secretory function: implication in metabolic and cardiovascular complications of obesity].J Soc Biol. 2006;200(1):37-43. doi: 10.1051/jbio:2006005. J Soc Biol. 2006. PMID: 17144160 Review. French.
-
The adipose tissue as an endocrine organ.Semin Nephrol. 2013 Jan;33(1):2-13. doi: 10.1016/j.semnephrol.2012.12.008. Semin Nephrol. 2013. PMID: 23374889 Review.
-
Adipose stem cells in obesity: challenges and opportunities.Biosci Rep. 2020 Jun 26;40(6):BSR20194076. doi: 10.1042/BSR20194076. Biosci Rep. 2020. PMID: 32452515 Free PMC article. Review.
Cited by
-
Roles for peroxisome proliferator-activated receptor γ (PPARγ) and PPARγ coactivators 1α and 1β in regulating response of white and brown adipocytes to hypoxia.J Biol Chem. 2012 May 25;287(22):18351-8. doi: 10.1074/jbc.M112.350918. Epub 2012 Apr 9. J Biol Chem. 2012. PMID: 22493496 Free PMC article.
-
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases.Int J Mol Sci. 2019 Oct 2;20(19):4888. doi: 10.3390/ijms20194888. Int J Mol Sci. 2019. PMID: 31581657 Free PMC article. Review.
-
IL-6 regulates adipose deposition and homeostasis in lymphedema.Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1426-34. doi: 10.1152/ajpheart.01019.2013. Epub 2014 Mar 14. Am J Physiol Heart Circ Physiol. 2014. PMID: 24633552 Free PMC article.
-
Efficacy of AdipoDren® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability.J Vasc Res. 2016;53(5-6):255-268. doi: 10.1159/000452798. Epub 2016 Dec 7. J Vasc Res. 2016. PMID: 27923233 Free PMC article.
-
Loss of Fatty Acid Binding Protein 4/aP2 Reduces Macrophage Inflammation Through Activation of SIRT3.Mol Endocrinol. 2016 Mar;30(3):325-34. doi: 10.1210/me.2015-1301. Epub 2016 Jan 20. Mol Endocrinol. 2016. PMID: 26789108 Free PMC article.
References
-
- Rajala MW, Scherer PE. Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765–3773. - PubMed
-
- Chudek J, Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep. 2006;58(Suppl):81–88. - PubMed
-
- Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med. 2007;120:S10–16. discussion S16–17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R24 DK071030-01/DK/NIDDK NIH HHS/United States
- R01-DK55758/DK/NIDDK NIH HHS/United States
- F32-DK081279/DK/NIDDK NIH HHS/United States
- R01-CA112023/CA/NCI NIH HHS/United States
- R24-DK071030-01/DK/NIDDK NIH HHS/United States
- R01 DK055758-10/DK/NIDDK NIH HHS/United States
- T32-HL007360-31A1/HL/NHLBI NIH HHS/United States
- T32 HL007360-31A1/HL/NHLBI NIH HHS/United States
- R01 DK055758/DK/NIDDK NIH HHS/United States
- R01 CA112023/CA/NCI NIH HHS/United States
- F32 DK081279-02/DK/NIDDK NIH HHS/United States
- F32 DK081279/DK/NIDDK NIH HHS/United States
- T32 HL007360/HL/NHLBI NIH HHS/United States
- R24 DK071030/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical